Compound-Condensate Interaction Screening via Partition and Binding Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective techniques for identifying and characterizing interactions between compounds and biological condensates, which are crucial for understanding cellular processes and therapeutic efficacy, due to limited understanding of mechanisms governing condensate partitioning and compound interactions.
Innovation Solution
A method is developed to identify interactions between test compounds and target condensates by measuring partition characteristics, binding affinity, and phase boundary characteristics, allowing for the comparison of these properties to determine specific interactions and design compounds with desired profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods are used to study compound interactions, then existing knowledge frameworks can be applied, but the ability to identify and characterize condensate interactions is insufficient
Solution Approach 1:
The invention segments the interaction characterization into three distinct measurable parameters: partition characteristic (compound distribution between condensate and light phase), binding affinity characteristic (compound binding to condensate components), and phase boundary characteristic (condensate formation conditions). This segmentation allows systematic study of compound-condensate interactions that would otherwise be intractable as a single complex problem.
Solution Approach 2:
The invention introduces an intermediary analysis framework that uses measurable physical and chemical parameters as mediators between the compound and condensate system. By measuring partition characteristics, binding affinity, and phase boundary properties, the method creates an intermediary layer of quantifiable data that enables identification of interaction mechanisms without directly observing the complex molecular processes.
2Loss of information
If comprehensive interaction characterization is performed, then detailed understanding of compound-condensate mechanisms is achieved, but the complexity of the analysis method increases
Solution Approach 1:
The invention creates a universal characterization framework that can be applied to any compound-condensate interaction system using the same three parameters. This multi-functional approach allows the same methodological framework to study different condensate types (membrane-less organelles, stress granules, P-bodies) and various compound classes (small molecules, peptides, proteins), reducing the need for system-specific complex analyses.
Solution Approach 2:
The invention transforms the complex interaction problem into parameter space by changing the description from direct molecular interaction mechanisms to measurable physical parameters. By expressing interactions in terms of partition characteristics, binding affinity values, and phase boundary conditions, the method simplifies the analysis while maintaining comprehensive information about the interaction mechanisms.
3Reliability
If therapeutic compound design is optimized for condensate interactions, then therapeutic potency and safety are improved, but the ability to predict condensate-associated characteristics is insufficient
Solution Approach 1:
The invention establishes a feedback loop where measured partition characteristics, binding affinity values, and phase boundary properties are used to identify interaction mechanisms, which then feed back into compound design and prediction models. This feedback enables iterative optimization of therapeutic compounds with desired condensate interactions and improves prediction accuracy through continuous refinement based on experimental data.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate identification and design of compounds that interact with condensates in specific ways, improving therapeutic potency, safety, and predicting condensate-associated characteristics, facilitating the development of effective therapeutic agents.
Implementation Method 1
These membrane-less molecular assemblies have been shown to be formed through a process termed liquid-liquid phase separation (LLPS) or condensation.
Implementation Method 2
a binding affinity characteristic of the test compound, or the portion thereof, for the component of the target condensate in a light phase
Implementation Method 3
a phase boundary characteristic of the component of the target condensate in the presence of the test compound, or the portion thereof
Data Source
AI summary
In some aspects, provided herein are methods of identifying interactions of a compound and a condensate, or a component thereof, and uses thereof. In other aspects, provided herein are methods of identifying (or screening for or designing) compounds, or portions thereof, having a desired interaction with a condensate, or a component thereof. In yet other aspects, provided herein are applications of the methods described herein, e.g., libraries of compounds having known or predicted characteristics, and methods of identifying compounds useful for treatment of a disease.